This is a SEO version of Full English Winter Magazine. Click here to view full version« Previous Page Table of Contents Next Page »
Winter 2014 • 5 4 • The Optimist
Meet Allison Martin, MD, Our 2013-2014 Optimist Fellow...
As a trainee in pediatric oncology who plans to specialize in the care of children with brain tumors, I am dedicated to improving treatment outcomes for these patients through
research. Brain tumors are the most common solid tumors in children, and despite advances in pediatric neuro-oncology, these tumors continue to be the leading cause of cancer death in children. Moreover, standard therapies often leave children with signifcant impairments, including severe neurocognitive problems.
Thanks to the generous support of Optimist International, I will continue to seek new approaches to treatment that will reduce these side effects by going beyond the traditional paradigm of chemotherapy and radiation. I hope to improve outcomes for these patients by reducing the toxicity of treatment and offering longer disease-free survival through the durability of the immune response.
Optimist International contributed $32,000 during the 2012-2013 year. On September 11, an additional $100,000 was donated to Johns Hopkins.
Dear Optimist Members –
The Johns Hopkins Division of Pediatric Oncology is dedicated to saving the lives of children with cancer. A place for brilliant research and compassionate care, it is also a place of laughter and tears, wins and losses, hopes and prayers. Here, superb caregivers do the toughest jobs of all with skill, courage and amazing grace.
combined modality treatments have reversed the odds and today nearly eighty percent of children can be cured. This has required an enormous investment, but this investment will continue to richly pay of f. Every day, children are saved. But still, twenty percent of those children entrusted to us will die. This intolerable thought motivates our researchers toward understanding how cancers grow. The urgent challenge is to conceive more ef fective and less toxic ways to diagnose, cure and ultimately prevent cancer.
There is nothing more beautiful than seeing research lead to cures.
The molecular tools and the growing understanding that biomedical science has put at our command is incredibly power ful. The time is here to give these children an even better fghting chance of survival.
This is why our par tnership with Optimist International is so critical. The Optimist International Innovative Research Fund and the Scholar program allow us the oppor tunity to develop new treatments for those patients who have not been cured. With your continued support, we will give these children a future of dreams, possibilities and accomplishments.
Stephanie Rice Davis, MSW Sr. Associate Director
Johns Hopkins Pediatric Oncology
Optimist International is committed to “providing the care and fnding the cure” for childhood cancer and pleased to be partnering with Johns Hopkins in this ef fort. This dedication is evident in the generous contributions received from Members, Clubs and Districts.
On September 11, Past International President Jack Creswell, Sue Creswell and Guy Templin from the Atlantic Central District presented a check for $100,000 to the staf f at Johns Hopkins. The funds were donated as part of the Optimist International Innovative Research Fund, which will expand clinical and research programs in childhood leukemias, pediatric brain tumors, sarcomas and other solid tumors and bone marrow transplantation. The Optimist guests received a tour of the facility and learned more about the innovative work being done by Johns Hopkins researchers.
A Word of Thanks
From Johns Hopkins...
“ There is nothing more beautiful
than seeing research lead to cures.”